Search

everythinglearnresearchcommunity

for

Search:↓

The AndroCoV Clinical Scoring is a quick, affordable, and accurate method for diagnosing COVID-19.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Ritlecitinib is effective and safe for treating severe alopecia areata, showing significant hair regrowth and improved mental health.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

CTCL patients can safely continue treatment during COVID-19 with proper safety measures.

The document sets guidelines to standardize reporting of PRP clinical trials for better reproducibility and comparability.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

"D-CHRAMPS syndrome" is a newly identified condition with multiple severe symptoms.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

Biologics for severe asthma have known side effects, but some new risks need more study.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Abrocitinib significantly improved hair regrowth in adolescents with alopecia areata without serious safety issues.

The study found that treatment improved hair condition in patients with Fibrosing Alopecia in a Pattern Distribution in Chile.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Letrozole combined with Cabergoline improves ovulation and pregnancy rates in women with PCOS and high prolactin levels compared to Letrozole alone.

A new gene variant in a girl with Coffin-Lowry Syndrome may link the condition to early puberty.

More research with diverse participants is needed to determine the effectiveness of photobiomodulation devices for hair loss treatment.

A single dose of Platelet Rich Plasma effectively reduces symptoms of early knee osteoarthritis.

The cooling system effectively and safely treats benign pigmented lesions in Asians.

Integrating biological networks improves drug repurposing and ADR prediction.

Daylight photodynamic therapy is effective and well-tolerated for treating actinic keratoses with minimal side effects.

Pulse corticosteroid therapy helps many with severe alopecia areata regrow hair, but has side effects.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

Individualized treatments may help manage Dercum's disease symptoms.

Avacopan is generally safe, with some minor side effects like nausea and fatigue.